UROGEN PHARMA - Stock Price History | URGN
Historical daily share price chart and data for UROGEN PHARMA since 2021 adjusted for splits. The latest closing stock price for UROGEN PHARMA as of September 27, 2021 is 17.94.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high UROGEN PHARMA stock closing price was 65.33 on May 18, 2018.
- The UROGEN PHARMA 52-week high stock price is 28.20, which is 57.2% above the current share price.
- The UROGEN PHARMA 52-week low stock price is 14.19, which is 20.9% below the current share price.
- The average UROGEN PHARMA stock price for the last 52 weeks is 19.03.
|UROGEN PHARMA Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
UroGen Pharma Ltd. is a clinical stage biopharmaceutical company. It focused on developing urological pathologies with a focus on uro-oncology. The company's product candidates include MitoGel and VesiGel which are in clinical trial stage. Its platform technologies include: RTGel and Immunotherapy. UroGen Pharma Ltd. is based in Ra'anana, Israel.